Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Boan Biotech announced today that the first patient in Phase III clinical trial of its Nivolumab Injection in China has been enrolled BA is the first biosimilar to Opdivo to undergo a Phase III study in China
Bridge Biotherapeutics a South Korean clinicalstage biotech company developing novel drugs for cancer fibrosis and inflammation announced that the company has initiated the Phase clinical trial evaluating the safety
Sun Pharmaceutical Industries Limited Reuters SUNBO Bloomberg SUNP IN NSE SUNPHARMA BSE Sun Pharma and includes its subsidiaries andor associate companies and Zydus Lifesciences Limited
Coherus BioSciences Inc and Shanghai Junshi Biosciences Co Ltd today announced that the US Food and Drug Administration approved LOQTORZI in combination with cisplatin and gemcitabine for the firstline treatment of adults with metastatic
Fapon a leading life sciences company entered into a strategic cooperation agreement with two Swiss biotech companies LASCCO SA and Abionic SA that granted Fapon an exclusive license to utilize the pancreatic stone protein biomarker for sepsis diagno...
Clarity Pharmaceuticals a clinical stage radiopharmaceutical company with a mission to develop nextgeneration products that improve treatment outcomes for children and adults with cancer and PSI CRO AG
Skye Bioscience Inc a pharmaceutical company developing drugs targeting the endocannabinoid system initially focused on the CB receptor to address glaucoma and metabolic conditions
Renibus Therapeutics a clinicalstage biopharmaceutical company focusing on the prevention and treatment of cardiorenal and metabolic diseases today announced that the first patient has been dosed in the pivotal Phase PROTECT trial
Roquette a global leader in plantbased ingredients and leading provider of pharmaceutical and nutraceutical excipients is pleased to announce the addition of three new excipient grades to its unmatched portfolio of solutions
Citius Pharmaceuticals Inc a biopharmaceutical company developing and commercializing firstinclass critical care products and TenX Keane Acquisition a publicly traded special purpose acquisition company
